Abstract: The present invention revolutionizes the field of mobile screen covers. The invention pertains to foldable Display Shades for computing devices with screen. More specifically, the invention pertains to covering the screen of computing devices with foldable side wings and top wing, creating a Shadow Box against unwanted lights for better visibility and for more privacy at the same time.

Abstract: The present invention generally relates to shock absorbing systems. These can be employed in such diverse objects as footwear apparel, mattresses, chair pillows, and seat covers. The present invention revolutionizes the field of shock absorbing systems. It utilizes a mass of flexible objects, such as air-filled balls, within a flexible container. The present invention utilizes a more comfortable mix than the mix of rubber and plastic sold in commercial footwear. The present invention utilizes layering and lubrication to increase flexibility and comfort.

Abstract: Microsampling system for small amounts of fluid samples for analysis in the vapour phase, which comprises a plurality of integrated functional units and is suitable for small sample quantities with fast reaction times.

Abstract: Device for carrying out photochemical processes on a microscale and use of the device for photochemical reactions and culturing photosynthesizing cells and/or microorganisms.

Abstract: The invention relates to a device for drawing a sample and analyzing body fluids, and to a corresponding method. The device comprises a handle (1), which accommodates a pneumatic drive device, and a sensor unit (2) that contains a microneedle (3) on an elastic membrane (4) and at least one sensor system (5). The handle (1) and the sensor unit are detachably connected to one another, and the pneumatic drive device interacts with the sensor unit (2) in such a manner that the drive device exerts pressure onto the elastic membrane (4) so that the microneedle (3) pierces the surface of the skin in order to draw body fluid. During the ensuing decreasing pressure, the elastic membrane (4) returns to its original shape, and body fluid is suctioned, due to the resulting underpressure, from the location of piercing and into the interior of the sensor unit (2) to the at least one sensor system (5).

Abstract: N-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride, its stereoisomers, and the addition salts thereof, pharmaceutical compositions containing the same, methods of treating pathological insulin resistance, methods of treating pathological insulin resistance and pathological conditions associated therewith, and methods of treating pathological insulin resistance by simultaneously treating diabetes-induced chronic complications, especially retinopathy, neuropathy and nephropathy, and/or by simultaneously increasing pathologically decreased peripheral neuroregeneration caused by diabetes.

Abstract: The invention refers to a new microbial process for preparing .beta.,.delta.-dihydroxy-7-[1,2,6,7,8,8a-hexahydro-2.6-dimethyl-8-(2-methy l-butyryloxy)-naphthalen-1-yl]-heptanoic acid .delta.-lactone of formula (I) and .beta.,.delta.-dihydroxy-7-[1,2,6,7,8,8a-hexahydro-2.6-dimethyl-8-(2-methy lbutyryloxy)-naphtalen-1-yl]-heptanoic acid of formula (II), ##STR1## by the aerobic fermentation of the submerged culture of an imperfect fungus strain biosynthesizing the above compounds, in a nutrient medium containing utilizable carbon and nitrogen sources as well as mineral salts, and by isolating the product of formula (I), which comprises cultivating a strain of the new Aspergillus obscurus fungus species producing the above compound(s) of formulas (I) and/or (II), in a temperature range of 25.degree. to 30.degree. C. and, if desired, separating the product(s) formed from the fermentation broth, then isolating it in the lactone form of formula (I) and, if desired, purifying the same.

Abstract: The invention relates to a microbial process for the production of immunosuppressive cyclosporine antibiotic complex or of its components, cyclosporine A, cyclosporine B and cyclosporine C, by the aerobic fermentation of a filamentous fungus strain biosynthesizing the above antibiotic(s) in a nutrient medium containing utilizable carbon and nitrogen sources as well as mineral salts, and by isolating the products formed, which comprises culturing a strain of the novel Tolypocladium varium fungus species producing the cyclosporine antibiotic complex, preferably tolypocladium varium sp. nov. CY/93, deposited at the National Collection of Agricultural and Industrial Microorganisms, Budapest, Hungary under the number NCAIM(P)F 001005, on a nutrient medium containing carbon sources, organic and inorganic nitrogen sources as well as mineral salts, under aerobic conditions, at 25.degree. to 30.degree. C., and, if desired, isolating and purifying the cyclosporine antibiotic complex or its components produced.